S. Zhou, M. Deng, X. Bian, J. Shi, R. Liang, and M. Tao, “Synergistic anti-tumor effects of lenalidomide and gefitinib by upregulating ADRB2 and inactivating the mTOR/PI3K/AKT signaling pathway in lung adenocarcinoma: Role of ADRB2 and mTOR/PI3K/AKT in LUAD”, Cell Mol Biol (Noisy-le-grand), vol. 70, no. 2, pp. 120–127, Feb. 2024.